The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jul 15, 2026 | Garber Alan M | Director | Grant(A) | 32 | $475.28 | $15K |
| Jul 15, 2026 | Sachs Bruce I | Director | Grant(A) | 100 | $475.28 | $47K |
| Jul 2, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell(S) | 2K | $519.00 | $800K |
| Jul 2, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell(S) | 2K | $524.99 | $787K |
| Jul 1, 2026 | Liu Joy | EVP and Chief Legal Officer | Sell(S) | 828 | $502.71 | $416K |
| Jun 26, 2026 | Bozic Carmen | EVP and CMO | Sell(S) | 596 | $482.50 | $288K |
| Jun 18, 2026 | Bozic Carmen | EVP and CMO | Sell(S) | 1K | $462.17 | $471K |
| Jun 15, 2026 | Bozic Carmen | EVP and CMO | Sell(S) | 4K | $450.00 | $1.8M |
| Jun 5, 2026 | Bozic Carmen | EVP and CMO | Sell(S) | 2K | $450.00 | $785K |
| Jun 1, 2026 | Liu Joy | EVP and Chief Legal Officer | Sell(S) | 828 | $439.91 | $364K |
| May 29, 2026 | Bozic Carmen | EVP and CMO | Sell(S) | 2K | $450.00 | $888K |
| May 15, 2026 | Bozic Carmen | EVP and CMO | Sell(S) | 1K | $453.45 | $614K |
| May 15, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell(S) | 33 | $453.45 | $15K |
| May 12, 2026 | Bozic Carmen | EVP and CMO | Sell(S) | 7K | $450.00 | $3.1M |
| May 4, 2026 | Bhatia Sangeeta N. | Director | Sell(S) | 318 | $423.73 | $135K |
| May 1, 2026 | McKenzie Diana | Director | Grant(A) | 943 | — | $0 |
| May 1, 2026 | McKenzie Diana | Director | Disposed to issuer(D) | 796 | — | — |
| May 1, 2026 | McKenzie Diana | Director | Grant(A) | 796 | — | — |
| May 1, 2026 | Bhatia Sangeeta N. | Director | Grant(A) | 943 | — | $0 |
| May 1, 2026 | Carney Lloyd | Director | Grant(A) | 3K | — | $0 |
| May 1, 2026 | Liu Joy | EVP and Chief Legal Officer | Sell(S) | 1K | $425.02 | $469K |
| May 1, 2026 | Garber Alan M | Director | Grant(A) | 472 | — | $0 |
| May 1, 2026 | Garber Alan M | Director | Grant(A) | 1K | — | $0 |
| May 1, 2026 | Thornberry Nancy | Director | Grant(A) | 472 | — | $0 |
| May 1, 2026 | Thornberry Nancy | Director | Disposed to issuer(D) | 398 | — | — |
| May 1, 2026 | Thornberry Nancy | Director | Grant(A) | 1K | — | $0 |
| May 1, 2026 | Thornberry Nancy | Director | Grant(A) | 398 | — | — |
| May 1, 2026 | Lagarde Michel | Director | Grant(A) | 3K | — | $0 |
| May 1, 2026 | Sachs Bruce I | Director | Grant(A) | 3K | — | $0 |
| May 1, 2026 | Schneider Jennifer | Director | Grant(A) | 472 | — | $0 |
| May 1, 2026 | Schneider Jennifer | Director | Disposed to issuer(D) | 796 | — | — |
| May 1, 2026 | Schneider Jennifer | Director | Grant(A) | 1K | — | $0 |
| May 1, 2026 | Schneider Jennifer | Director | Grant(A) | 796 | — | — |
| May 1, 2026 | Upadhyay Suketu | Director | Disposed to issuer(D) | 796 | — | — |
| May 1, 2026 | Upadhyay Suketu | Director | Grant(A) | 3K | — | $0 |
| May 1, 2026 | Upadhyay Suketu | Director | Grant(A) | 796 | — | — |
| Apr 15, 2026 | Sachs Bruce I | Director | Grant(A) | 107 | $442.50 | $48K |
| Apr 15, 2026 | Garber Alan M | Director | Grant(A) | 34 | $442.50 | $15K |
| Apr 15, 2026 | Upadhyay Suketu | Director | Grant(A) | 81 | $442.50 | $36K |
| Apr 1, 2026 | Liu Joy | EVP and Chief Legal Officer | Sell(S) | 978 | $449.17 | $439K |
| Mar 27, 2026 | Bozic Carmen | EVP and CMO | Sell(S) | 2K | $450.95 | $1.1M |
| Mar 13, 2026 | Bozic Carmen | EVP and CMO | Sell(S) | 2K | $481.79 | $1.1M |
| Mar 11, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell(S) | 3K | $498.42 | $1.3M |
| Mar 4, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell(S) | 2K | $475.30 | $1.2M |
| Mar 2, 2026 | Liu Joy | EVP and Chief Legal Officer | Sell(S) | 892 | $495.96 | $442K |
| Feb 27, 2026 | Bozic Carmen | EVP and CMO | Sell(S) | 2K | $480.31 | $1.1M |
| Feb 27, 2026 | Kewalramani Reshma | CEO & President, Director | Sell(S) | 3K | $488.27 | $1.6M |
| Feb 27, 2026 | Kewalramani Reshma | CEO & President, Director | Sell(S) | 3K | $487.13 | $1.2M |
| Feb 27, 2026 | Kewalramani Reshma | CEO & President, Director | Sell(S) | 240 | $482.84 | $116K |
| Feb 27, 2026 | Kewalramani Reshma | CEO & President, Director | Sell(S) | 120 | $481.50 | $58K |
| Feb 27, 2026 | Kewalramani Reshma | CEO & President, Director | Sell(S) | 400 | $479.75 | $192K |
| Feb 27, 2026 | Kewalramani Reshma | CEO & President, Director | Sell(S) | 460 | $489.32 | $225K |
| Feb 27, 2026 | Kewalramani Reshma | CEO & President, Director | Sell(S) | 2K | $496.95 | $857K |
| Feb 27, 2026 | Kewalramani Reshma | CEO & President, Director | Sell(S) | 6K | $496.16 | $3.0M |
| Feb 27, 2026 | Kewalramani Reshma | CEO & President, Director | Sell(S) | 3K | $490.54 | $1.3M |
| Feb 27, 2026 | Kewalramani Reshma | CEO & President, Director | Sell(S) | 949 | $491.30 | $466K |
| Feb 27, 2026 | Kewalramani Reshma | CEO & President, Director | Sell(S) | 3K | $493.29 | $1.2M |
| Feb 27, 2026 | Kewalramani Reshma | CEO & President, Director | Sell(S) | 3K | $494.33 | $1.7M |
| Feb 27, 2026 | Kewalramani Reshma | CEO & President, Director | Sell(S) | 16K | $495.38 | $7.7M |
| Feb 26, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell(S) | 357 | $483.36 | $173K |
| Feb 25, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell(S) | 223 | $486.35 | $108K |
| Feb 25, 2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell(S) | 668 | $486.35 | $325K |
| Feb 25, 2026 | Biller Jonathan | EVP and Chief Legal Officer | Sell(S) | 945 | $486.35 | $460K |
| Feb 25, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell(S) | 620 | $486.35 | $302K |
| Feb 25, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell(S) | 2K | $489.00 | $1.2M |
| Feb 25, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | Sell(S) | 3K | $486.35 | $1.2M |
| Feb 25, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell(S) | 2K | $486.35 | $898K |
| Feb 25, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell(S) | 260 | $486.35 | $126K |
| Feb 24, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | Tax withholding(F) | 546 | $485.11 | $265K |
| Feb 24, 2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Tax withholding(F) | 2K | $485.11 | $789K |
| Feb 24, 2026 | Biller Jonathan | EVP and Chief Legal Officer | Tax withholding(F) | 1K | $485.11 | $555K |
| Feb 24, 2026 | Bozic Carmen | EVP and CMO | Tax withholding(F) | 1K | $485.11 | $705K |
| Feb 24, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | Tax withholding(F) | 582 | $485.11 | $282K |
| Feb 24, 2026 | Kewalramani Reshma | CEO & President, Director | Tax withholding(F) | 5K | $485.11 | $2.4M |
| Feb 24, 2026 | McKechnie Duncan | EVP, Chief Commercial Officer | Tax withholding(F) | 873 | $485.11 | $424K |
| Feb 24, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Tax withholding(F) | 2K | $485.11 | $736K |
| Feb 24, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Tax withholding(F) | 2K | $485.11 | $789K |
| Feb 24, 2026 | Wagner Charles F JR | EVP, CO & FO | Tax withholding(F) | 2K | $485.11 | $846K |
| Feb 24, 2026 | Leiden Jeffrey M | Executive Chairman, Director | Tax withholding(F) | 4K | $485.11 | $1.7M |
| Feb 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell(S) | 3K | $465.05 | $1.3M |
| Feb 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell(S) | 4K | $471.43 | $2.0M |
| Feb 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Option exercise(M) | 23K | $155.57 | $3.7M |
| Feb 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Option exercise(M) | 25K | $187.53 | $4.7M |
| Feb 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell(S) | 920 | $463.91 | $427K |
| Feb 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell(S) | 2K | $465.80 | $861K |
| Feb 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell(S) | 10K | $467.75 | $4.8M |
| Feb 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell(S) | 20K | $468.57 | $9.2M |
| Feb 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell(S) | 7K | $469.61 | $3.4M |
| Feb 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Sell(S) | 12K | $470.54 | $5.5M |
| Feb 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Option exercise(M) | 25K | — | $0 |
| Feb 19, 2026 | Sachdev Amit | EVP Chief Patient & Ext Af Off | Option exercise(M) | 23K | — | $0 |
| Feb 18, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell(S) | 638 | $473.68 | $302K |
| Feb 18, 2026 | Atkinson Edward Morrow III | EVP, Chief Technical Ops. Off. | Sell(S) | 817 | $473.68 | $387K |
| Feb 18, 2026 | Biller Jonathan | EVP and Chief Legal Officer | Sell(S) | 1K | $473.68 | $589K |
| Feb 18, 2026 | Bunnage Mark E. | EVP, Chief Scientific Officer | Sell(S) | 1K | $473.68 | $560K |
| Feb 18, 2026 | Leiden Jeffrey M | Executive Chairman, Director | Tax withholding(F) | 3K | $483.75 | $1.4M |
| Feb 18, 2026 | Tatsis Ourania | EVP, Chief Reg. & Quality Off. | Sell(S) | 368 | $473.68 | $174K |
| Feb 17, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | Grant(A) | 2K | — | $0 |
| Feb 17, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | Tax withholding(F) | 598 | $483.75 | $289K |
| Feb 17, 2026 | Ambrose Kristen | SVP & Chief Accounting Officer | Sell(S) | 2K | $489.46 | $762K |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Coverage: Form 4 filings indexed 2021-01-04 → 2026-07-20. Earlier history is backfilling; this window widens as it deepens.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).